Alkem Laboratories539523Board meeting scheduled
Board meeting on 12th November, 2026 to approve Q2 and H1 results
Board meeting of Alkem Laboratories is scheduled for Thursday, 12th November, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Thursday, 12th November, 2026
- Agenda Period
- quarter and half year ended 30th September, 2026
- Exchanges Notified
- BSE (Scrip Code: 539523) and NSE (Scrip Symbol: ALKEM)
What the update says
- The Board of Directors is scheduled to meet on Thursday, 12th November, 2026.
- The meeting will take up, among other things, the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2026, for consideration and approval.
- The notice has been given to BSE (Scrip Code: 539523) and NSE (Scrip Symbol: ALKEM).
What this means for a retail investor
- This is a calendar announcement. It tells the market the date on which Alkem's April-June... rather, July-September quarter numbers are expected to be approved by the Board.
- The actual revenue, profit, margin and segment figures are not part of this notice. They become public only when the results are approved and shared.
- A board meeting notice does not by itself change anything about the business; it only sets the date on which the reported performance will be known.
How to read the upcoming results
- The update refers to both standalone and consolidated results. Consolidated numbers include the company's subsidiaries and give the fuller picture of the group; standalone covers the parent entity.
- Because the period is a half year as well as a quarter, the disclosure will show both the three-month and the six-month performance.
- Investors usually compare the numbers with the same period a year earlier and with the immediately preceding quarter to see the direction of sales and profits.
Key dates to note
- Board meeting: 12th November, 2026.
- Period being reported: quarter and half year ended 30th September, 2026.
- This notice itself is dated 4th November, 2026.
Also from Alkem Laboratories
Alkem Laboratories to hold Q2 and H1FY27 earnings conference call on November 12, 2026, hosted by Motilal Oswal Securities
4 Nov 2026
Alkem Laboratories to host Q2FY27 and H1FY27 earnings conference call on November 12, 2026
4 Nov 2026
Dr. Amrut Naik appointed CEO and Key Managerial Personnel with effect from 11 November 2026
3 Nov 2026
Source: BSE · 4 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.